A New Breakthrough in Early Detection of Alzheimer’s Disease Risk
Dr. Michael Racke, a board-certified neurologist and medical director of neurology at Quest Diagnostics, discusses the advances in blood and other tests for Alzheimer’s Disease. He’ll also talk about other practical ways to talk to healthcare providers about the disease, new research that shows how lifestyle changes may reduce risk, and questions people should ask their doctor to assess their own risk. For more information visit questforthecure.com
Dr. Michael K. Racke is Medical Director for Neurology at Quest Diagnostics, the leading provider of diagnostic information services and provider of AD-Detect, a portfolio of blood tests for assessing Alzheimer’s risk. He is a leader in the field of neurology and has over three decades of leadership experience in academia and clinical practice and continues to serve on several national professional society committees. Dr. Racke is board certified and is a member of the American Academy of Neurology and American Associations of Immunologists.
